No two people are the same, and neither are cancer tumors. The first step to smarter fighting cancer begins with uncovering the mutations that drive each person’s cancer. Precision medicine utilizes genomic information to tailor diagnoses and treatments to each patient’s cancer.

LiquidHALLMARK® detects cancer-driving gene mutations and viruses in each patient’s tumor from a single blood draw, allowing physicians to make more informed decision for their patients’ care.